GB0205963D0 - Biological materials and methods useful in the diagnosis and treatment of diseases - Google Patents

Biological materials and methods useful in the diagnosis and treatment of diseases

Info

Publication number
GB0205963D0
GB0205963D0 GBGB0205963.2A GB0205963A GB0205963D0 GB 0205963 D0 GB0205963 D0 GB 0205963D0 GB 0205963 A GB0205963 A GB 0205963A GB 0205963 D0 GB0205963 D0 GB 0205963D0
Authority
GB
United Kingdom
Prior art keywords
diagnosis
diseases
treatment
biological materials
methods useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0205963.2A
Other versions
GB2371049B (en
GB2371049A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824091.4A external-priority patent/GB9824091D0/en
Priority claimed from GBGB9906217.6A external-priority patent/GB9906217D0/en
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority claimed from GB0113011A external-priority patent/GB2362385B/en
Publication of GB0205963D0 publication Critical patent/GB0205963D0/en
Publication of GB2371049A publication Critical patent/GB2371049A/en
Application granted granted Critical
Publication of GB2371049B publication Critical patent/GB2371049B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
GB0205963A 1998-11-04 1999-11-01 Methods of making antibodies against ß-forms of prion proteins and their uses Expired - Fee Related GB2371049B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9824091.4A GB9824091D0 (en) 1998-11-04 1998-11-04 Biological materials and methods useful in the diagnosis and treatment of diseases
GBGB9906217.6A GB9906217D0 (en) 1999-03-18 1999-03-18 Biological materials and methods useful in the diagnosis and treatment of diseases
GB0113011A GB2362385B (en) 1998-11-04 1999-11-01 Non-aggregated ß-forms of prion proteins

Publications (3)

Publication Number Publication Date
GB0205963D0 true GB0205963D0 (en) 2002-04-24
GB2371049A GB2371049A (en) 2002-07-17
GB2371049B GB2371049B (en) 2003-06-04

Family

ID=27256178

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0205963A Expired - Fee Related GB2371049B (en) 1998-11-04 1999-11-01 Methods of making antibodies against ß-forms of prion proteins and their uses

Country Status (1)

Country Link
GB (1) GB2371049B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU707484B2 (en) * 1995-09-14 1999-07-08 Regents Of The University Of California, The Antibodies specific for native PrPsc
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein

Also Published As

Publication number Publication date
GB2371049B (en) 2003-06-04
GB2371049A (en) 2002-07-17

Similar Documents

Publication Publication Date Title
GB9925804D0 (en) Biological materials and method useful in the diagnosis and treatment of diseases
ATE349428T1 (en) PROSTAGLAND INAGONISTS AND THEIR USE IN THE TREATMENT OF BONE DISEASES
IL205242A0 (en) Substituted oxazolidinones and their use in the field of blood coagulation
DE69805438D1 (en) MIXING AND CHARGING OPENING FOR MEDICAL TREATMENT
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
IL128894A0 (en) Materials and methods relating to the diagnosis and treatment of diabetes and obesity
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
GB0019302D0 (en) Biological materials and the use thereof for the treatment of disease
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
NO20020207L (en) Biological materials and methods useful in the diagnosis and treatment of disease
DE69636367D1 (en) T-PA POLYMORPHISM AND ITS USE IN THE RISK DIAGNOSIS OF THROMBUS ASSOCIATED DISEASES
AU2001253886A1 (en) Methylxanthines in the diagnosis and treatment of autistic disorder
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
GB9509461D0 (en) DNA molecules and constructs and their use in the treatment of mastitis
GB0113011D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB0205963D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9824091D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9908059D0 (en) Diagnosis and treatment of diseases
GB9906217D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9917878D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
EP1023076A4 (en) Use of the p-ten suppressor gene in diagnosis and treatment of cancer
GB9917491D0 (en) Biological materials and methods useful in the diagnosis and treastment of diseases
ZA9610584B (en) Use of rc-9 in diagnosis and treatment of proliferative arterial disease
GB9828564D0 (en) Materials and methods for the treatment and diagnosis of cancer
AU5875599A (en) Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20141101